Estrogen inhibits transforming growth factor β signaling by promoting Smad2/3 degradation

  • Ichiaki Ito
  • , Aki Hanyu
  • , Mitsutoshi Wayama
  • , Natsuka Goto
  • , Yoko Katsuno
  • , Shohei Kawasaki
  • , Yuka Nakajima
  • , Masashi Kajiro
  • , Yoko Komatsu
  • , Akiko Fujimura
  • , Ryuichi Hirota
  • , Akiko Murayama
  • , Keiji Kimura
  • , Takeshi Imamura
  • , Junn Yanagisawa

Research output: Contribution to journalArticlepeer-review

150 Scopus citations

Abstract

Estrogen is a growth factor that stimulates cell proliferation. The effects of estrogen are mediated through the estrogen receptors,ERα andERβ, which function as ligand-induced transcription factors and belong to the nuclear receptor superfamily. On the other hand, TGF-β acts as a cell growth inhibitor, and its signaling is transduced by Smads. Although a number of studies have been made on the cross-talk between estrogen/ERα and TGF-β/Smad signaling, whose molecular mechanisms remain to be determined. Here, we show that ERα inhibits TGF-β signaling by decreasing Smad protein levels. ERα-mediated reductions in Smad levels did not require the DNA binding ability of ERα, implying that ERα opposes the effects of TGF-β via a novel non-genomic mechanism. Our analysis revealed that ERα formed a protein complex with Smad and the ubiquitin ligase Smurf, and enhanced Smad ubiquitination and subsequent degradation in an estrogen-dependent manner. Our observations provide new insight into the molecular mechanisms governing the non-genomic functions of ERα.

Original languageEnglish (US)
Pages (from-to)14747-14755
Number of pages9
JournalJournal of Biological Chemistry
Volume285
Issue number19
DOIs
StatePublished - May 7 2010
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Estrogen inhibits transforming growth factor β signaling by promoting Smad2/3 degradation'. Together they form a unique fingerprint.

Cite this